drugset / Trial / NCT00055978
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
Phase 2
Completed
112 enrolled
University of California, Los Angeles
National Cancer Institute (NCI) · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. Celecoxib may be effective in preventing the development or recurrence of lung cancer in former heavy smokers. PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing the development or recurrence of lung cancer in former heavy smokers who are at risk of developing cancer.
Timeline
- Start
- 2002-10
- Primary completion
- 2008-03
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |